President-elect Donald Trump has announced the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS), a move that has sparked significant debate across the healthcare and political landscapes. Kennedy, a former independent presidential candidate and environmental lawyer, has been a vocal critic of the nation’s food safety standards and pharmaceutical industry practices. In his announcement, Trump stated that Kennedy would focus on ending the 'chronic disease epidemic' and addressing transparency in public health. The nomination has drawn a mixed response; supporters praise Kennedy’s focus on nutrition and corporate accountability, while public health experts express concern over his previous skepticism regarding vaccine efficacy and long-standing scientific consensus. Market analysts noted a decline in share prices for several major vaccine manufacturers following the news. The appointment will require Senate confirmation, where lawmakers are expected to closely scrutinize Kennedy’s policy positions and his vision for the country’s largest health agency.